The permeability of osteocyte-derived CM to the brain was determined by an ex vivo skull assay using mammary tumor cells as well as freshly isolated HER2-positive breast cancer tissue that is known to metastasize frequently to the brain [25,26,27]. This evidence concerns the gene ERBB2 and breast cancer.